Get started
Author

Lore Vanderbeke

Observed names: L. Vanderbeke, Lore vanderBeeke, Vanderbeke L, Vanderbeke Lore, Vanderbeke, L., Vanderbeke, Lore
ORCID: 0000-0002-3364-1213
Observed ORCID: 0000-0002-3364-1213
OpenAlex ID: A5055148071
Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: a retrospective cohort study
2018 · Alexander F A D Schauwvlieghe, Bart J A Rijnders, et al. · The Lancet Respiratory Medicine · 885
PDF
Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinion
2020 · Paul E. Verweij, Bart J. A. Rijnders, et al. · Intensive Care Medicine · 459
PDF
Discriminating mild from critical COVID-19 by innate and adaptive immune single-cell profiling of bronchoalveolar lavages
2021 · Els Wauters, Pierre Van Mol, et al. · Cell Research · 345
PDF
Monocyte-driven atypical cytokine storm and aberrant neutrophil activation as key mediators of COVID-19 disease severity
2021 · L. Vanderbeke, P. Van Mol, et al. · Nature Communications · 244
PDF
Invasive pulmonary aspergillosis complicating severe influenza: epidemiology, diagnosis and treatment
2018 · Lore Vanderbeke, Isabel Spriet, et al. · Current Opinion in Infectious Diseases · 151
PDF
Multinational Observational Cohort Study of COVID-19–Associated Pulmonary Aspergillosis1
2021 · Nico A.F. Janssen, Rémy Nyga, et al. · Emerging infectious diseases · 138
PDF
Autoantibodies against type I IFNs in patients with critical influenza pneumonia
2022 · Qian Zhang, Andrés Pizzorno, et al. · The Journal of Experimental Medicine · 132
Influenza-associated and COVID-19-associated pulmonary aspergillosis in critically ill patients
2024 · Simon Feys, Agostinho Carvalho, et al. · The Lancet Respiratory Medicine · 129
Lung epithelial and myeloid innate immunity in influenza-associated or COVID-19-associated pulmonary aspergillosis: an observational study
2022 · Simon Feys, Samuel M Gonçalves, et al. · The Lancet Respiratory Medicine · 124
PDF
Posaconazole for prevention of invasive pulmonary aspergillosis in critically ill influenza patients (POSA-FLU): a randomised, open-label, proof-of-concept trial
2021 · Lore Vanderbeke, Nico A. F. Janssen, et al. · Intensive Care Medicine · 99
PDF
Clinical practices underlie COVID-19 patient respiratory microbiome composition and its interactions with the host
2021 · Verónica Lloréns-Rico, Ann C. Gregory, et al. · Nature Communications · 88
PDF
Increased IL‐10‐producing regulatory T cells are characteristic of severe cases of COVID‐19
2020 · Julika Neumann, Teresa Prezzemolo, et al. · Clinical & Translational Immunology · 84
PDF
Atypical response to bacterial coinfection and persistent neutrophilic bronchoalveolar inflammation distinguish critical COVID-19 from influenza
2021 · Seppe Cambier, Mieke Metzemaekers, et al. · JCI Insight · 61
PDF
Convalescent plasma treatment of persistent severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) infection in patients with lymphoma with impaired humoral immunity and lack of neutralising antibodies
2020 · Albrecht Betrains, Laurent Godinas, et al. · British Journal of Haematology · 56
PDF
A Pathology-based Case Series of Influenza- and COVID-19–associated Pulmonary Aspergillosis: The Proof Is in the Tissue
2023 · Lore Vanderbeke, Cato Jacobs, et al. · American Journal of Respiratory and Critical Care Medicine · 53
High Burden of COVID-19-Associated Pulmonary Aspergillosis in Severely Immunocompromised Patients Requiring Mechanical Ventilation
2023 · Simon Feys, Katrien Lagrou, et al. · Clinical Infectious Diseases · 52
PDF
Kinetics of peripheral blood neutrophils in severe coronavirus disease 2019
2021 · Mieke Metzemaekers, Seppe Cambier, et al. · Clinical & Translational Immunology · 47
PDF
Severe COVID-19 patients display hyper-activated NK cells and NK cell-platelet aggregates
2022 · Bert Malengier-Devlies, Jessica Filtjens, et al. · Frontiers in Immunology · 46
PDF
C5aR1 signaling triggers lung immunopathology in COVID-19 through neutrophil extracellular traps
2023 · Bruna M. Silva, Giovanni F. Gomes, et al. · Journal of Clinical Investigation · 39
PDF
Early oseltamivir reduces risk for influenza-associated aspergillosis in a double-hit murine model
2021 · Laura Seldeslachts, Lore Vanderbeke, et al. · Virulence · 36
PDF
Lower respiratory tract single-cell RNA sequencing and neutrophil extracellular trap profiling of COVID-19-associated pulmonary aspergillosis: a single centre, retrospective, observational study
2024 · Simon Feys, Sam Vanmassenhove, et al. · The Lancet Microbe · 34
PDF
Neuraminidase and SIGLEC15 modulate the host defense against pulmonary aspergillosis
2021 · Intan M.W. Dewi, Cristina Cunha, et al. · Cell Reports Medicine · 31
PDF
Longitudinal multimodal imaging-compatible mouse model of triazole-sensitive and -resistant invasive pulmonary aspergillosis
2022 · Agustin Resendiz-Sharpe, Roberta Peres da Silva, et al. · Disease Models & Mechanisms · 25
PDF
967. Inhibition of Host Neuraminidase Increases Susceptibility to Invasive Pulmonary Aspergillosis
2018 · Frank Van De Veerdonk, Intan Dewi, et al. · Open Forum Infectious Diseases · 16
PDF
Profiling Bacteria in the Lungs of Patients with Severe Influenza Versus COVID-19 with or without Aspergillosis
2024 · Simon Feys, Martina Cardinali-Benigni, et al. · American Journal of Respiratory and Critical Care Medicine · 15
Works count: 48
Citation count: 3,459
H-index: 23
I10-index: 28
Year
Topic
Type